Pulished Date October, 2018
ID: 235
Share on
Share on

Europe Acute Ischemic Stroke Diagnosis And Treatment Market By Diagnostic Type (Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral Angiography And Nuclear Imaging) By Surgery Type (Carotid Endarterectomy, Angioplasty And Endovascular Mechanical Thrombectomy) And By Region- Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2028)

Pulished: October, 2018
ID: 235
Pages: 145

The Europe Acute Ischemic Stroke Treatment and Diagnosis Market was worth $462.75 million in 2018 and estimated to be growing at a CAGR of 6.4%, to reach $631.04 million by 2023. Acute Ischemic stroke can be defined as loss of function in certain parts of brain due to lack of blood supply to the brain.

Europe Ischemic stroke diagnostics and treatment market is driven by key factors such as increasing prevalence of acute ischemia stroke cases, technological advancements in surgical procedures along with rising geriatric population, growing demand for minimally invasive procedures and growth in healthcare spending whereas excessive usage of medication for the treatment of ischemic stroke and high cost of surgical procedures are restraining the market growth.

Europe Acute Ischemic Stroke Diagnosis and Treatment Market is segmented by Diagnostic type and by Surgery type.  By Diagnostic type the market is further sub-segmented into Computed Tomography, Ultrasound, Magnetic Resonance Imaging, Cerebral angiography and nuclear imaging. On the Basis of Surgery Type the market is segmented into Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy. Carotid Endarterectomy is the largest surgery type sub-segment accounting for a share of approximately XX% and is expected to maintain its strong share due to high success rate, short treatment duration and easy availability.

On the Basis of geography Europe Acute Ischemic Stroke Diagnosis and Treatment Market is analysed under various regions namely Germany, Italy, France, United Kingdom and Spain. Europe is the second largest for Acute Ischemic Stroke Diagnosis and Treatment devices accounting for a share of approximately XX% in 2018 due to favourable government initiatives, technological innovations. Within Europe, United Kingdom accounted for the largest share and is estimated to retain its strong share while Germany is estimated to be the fastest growing due to increasing prevalence

Some of the major companies covered in the report are Abbott Laboratories, Covidien plc, Philips Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare, Stryker Corporation (Concentric Medical, Inc.) and Hitachi, Ltd.

 

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Diagnostic Type                                                        

                                5.1.1 Computed Tomography                                    

                                5.1.2 Magnetic Resonance Imaging                                         

                                5.1.3 Ultrasound                                              

                                5.1.4 Cerebral angiography                                         

                                5.1.5 Nuclear Imaging                                    

                5.2 Surgery Type                                                             

                                5.2.1 Carotid Endarterectomy                                    

                                5.2.2 Angioplasty                                             

                                5.2.3 Endovascular Mechanical Thrombectomy                                 

6. Geographical Analysis                                                                              

                                6.1 Introduction                                               

                                6.2 U.K                                 

                                6.3 Spain                                             

                                6.4 Germany                                     

                                6.5 Italy                                               

                                6.6 France                                          

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Abbott Laboratories                                                               

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Covidien plc                                                

                8.3 Johnson & Johnson                                                 

                8.4 Penumbra, Inc.                                                         

                8.5 Philips Healthcare                                                    

                8.6 GE Healthcare                                                           

                8.7 Hitachi, Ltd.                                                

                8.8 Siemens Healthcare                                                

                8.9 Stryker Corporation                                                

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Acute Ischemic Stroke Diagnosis Market By Region, From 2018-2023 (USD Million)
  2. Europe Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2018-2023 (USD Million)
  3. Europe Computed Tomography Market By Region, From 2018-2023 (USD Million)
  4. Europe Magnetic Resonance Imaging Market By Region, From 2018-2023 (USD Million)
  5. Europe Ultrasound Market By Region, From 2018-2023 (USD Million)
  6. Europe Cerebral angiography Market By Region, From 2018-2023 (USD Million)
  7. Europe Nuclear Imaging Market By Region, From 2018-2023 (USD Million)
  8. Europe Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2018-2023 (USD Million)
  9. Europe Carotid Endarterectomy Market By Region, From 2018-2023 (USD Million)
  10. Europe Angioplasty Market By Region, From 2018-2023 (USD Million)
  11. Europe Endovascular Mechanical Thrombectomy Market By Region, From 2018-2023 (USD Million)
  12. U.K Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2018-2023 (USD Million)
  13. U.K Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2018-2023 (USD Million)
  14. Spain Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2018-2023 (USD Million)
  15. Spain Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2018-2023 (USD Million)
  16. Germany Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2018-2023 (USD Million)
  17. Germany Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2018-2023 (USD Million)
  18. Italy Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2018-2023 (USD Million)
  19. Italy Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2018-2023 (USD Million)
  20. France Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2018-2023 (USD Million)
  21. France Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2018-2023 (USD Million)

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients

Research Areas